Active ingredients
Pharmacological Group
Used in the treatment of
- R53 Malaise and fatigue
- R46.4 Slowness and poor responsiveness
- R45.7 State of emotional shock and stress, unspecified
- R45.4 Irritability and anger
- R45.3 Demoralization and apathy
- P20 Intrauterine hypoxia
- I69 Sequelae of cerebrovascular disease
- I63 Cerebral infarction
- G93.4 Encephalopathy, unspecified
- G47.0 Disorders of initiating and maintaining sleep [insomnias]
- G46 Vascular syndromes of brain in cerebrovascular diseases (I60-I67+)
- F91 Conduct disorders
- F79 Unspecified mental retardation
- F41.2 Mixed anxiety and depressive disorder
- F34.1 Dysthymia
- F10.2 Mental and behavioural disorders due to use of alcohol, dependence syndrome
- F10.3 Mental and behavioural disorders due to use of alcohol, withdrawal state
- F03 Unspecified dementia
- F01 Vascular dementia
- T90.5 Sequelae of intracranial injury
- P91.9 Disturbance of cerebral status of newborn, unspecified